Personalised Exercise
BehavioralAn individualized exercise program consisting of aerobic exercises, strength exercises and balance exercises. The exercises will be prescribed via the Physitrack app.
NCT Number: NCT06712043
The goal of this intervention study is to determine the effect of a tailored exercise program (with aerobic, strength and balance training) in patients with FSHD.
The main aim is to determine the effect of the exercise program on pain and fatigue.
Participants will follow a 16 week training program with tailored exercises. The exercises will be prescribed via the app 'Physitrack'. After 16 weeks, the effect on pain, fatigue, fatigability, aerobic capacity, balance, physical function, sleep and the ability to participate in social activities will be determined.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Rationale: Pain and fatigue are two common and disabling symptoms in FSHD. No studies in FSHD have proven to reduce pain yet. (Aerobic) exercise has proven to reduce fatigue, however, current training guidelines are generic which can lead to overuse of injuries. The investigators expect that a personalized training program with aerobic exercise but also strength and balance training, that is adapted to a participants symptoms and wishes will provide a positive effect on pain and fatigue.
Objectives:
Primary objectives
Main study parameters/endpoints:
The chronic fatigue score assessed using the Checklist Individual Strength (CIS-fatigue) fatigue subscale and the average daily pain score during 2 weeks are the primary endpoints.
Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Participating in this study includes: (1) two visits to the Radboudumc (approximately 3-4 hours, including a break) with physical test and questionnaires, (2) following a 16 week personalized exercise program, including filling in questionnaires about pain and fatigue and (3) wearing an activity tracker for 1 week before and after the study. Participants will have a weekly phone call with the researcher, and when participants will have complaints such as pain and/or fatigue, the training will be adapted. Therefore, the investigators expect that the risk will be minimal, and patient might experience the benefits of personalized training.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
An individualized exercise program consisting of aerobic exercises, strength exercises and balance exercises. The exercises will be prescribed via the Physitrack app.
Aerobic training (see study Voet 2024, Both aerobic exercise and cognitive-behavioral therapy reduce chronic fatigue in FSHD)
Time frame: 16 weeks
Daily observed pain during a period of 2 weeks, measured with the Visual Analog Scale (VAS)
Time frame: 16 weeks
The chronic fatigue score assessed using the Checklist Individual Strength (CIS-fatigue) fatigue subscale.
Time frame: 16 weeks
The quadriceps isometric intermittent fatigue test (QIF test)
Time frame: 16 weeks
VAS fatigue
Time frame: 16 weeks
B-FIT Exercise test
Time frame: 16 weeks
Maximal expiratory pressure (MEP)
Time frame: 16 weeks
Forced vital capacity (FVC)
Time frame: 16 weeks
Maximal inspiratory pressure (MIP)
Time frame: 16 weeks
Mini Balance Evaluation Systems Test (Mini-BESTest)
Time frame: 16 weeks
Brief pain inventory questionnaire
Time frame: 16 weeks
PROMIS Short Form v1.0 - Sleep Disturbance 8a
Time frame: 16 weeks
PROMIS Short Form v2.0 - Ability to Participate in Social Roles and Activities 8a
Time frame: 16 weeks
PROMIS Short Form v2.0 - Physical Function 20a.
Time frame: 16 weeks
Activity tracker
Contact information is provided by the study sponsor or research team.
Radboud University Medical Center
Other
Testing a Tailored Home Exercise Program to Gain Insight Into Performance Fatigability and Reduce Pain and Fatigue in Patients with FSHD: the GRIP on FSHD Study
Acronym: GRIPonFSHD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07435129
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, FSHD
View Trial DetailsNCT07038200
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, FSH Muscular Dystrophy
Orange, California, United States
View Trial DetailsNCT05747924
Atrophies, Facioscapulohumeral, Atrophy, Facioscapulohumeral
Los Angeles, California, United States
View Trial DetailsNCT06547216
Atrophies, Facioscapulohumeral, Atrophy, Facioscapulohumeral
Los Angeles, California, United States
View Trial Details